Currus Biologics
Ebony has significant experience in the management of preclinical drug development programs. She has previously worked with ASX-listed biotechnology company AdAlta and early-stage startup Gertrude Biomedical, coordinating their internal and external preclinical research activities. In addition to project management capabilities, Ebony has experience in technical market appraisal including opportunity analysis and reimbursement strategy. Ebony completed a PhD in Cancer Pharmacology at The University of Melbourne concurrently with a Graduate Certificate in Commercialisation at Melbourne Business School.
This person is not in the org chart
Currus Biologics
Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.